DrStore Healthcare Services India has announced a partnership with TatvaCare’s health and wellness app GoodFlip to expand access to Continuous Glucose Monitoring (CGM) technologies and strengthen digital diabetes care infrastructure in India.
The collaboration integrates DrStore’s connected medical device brand TRACKY, which introduced India’s first Bluetooth-enabled continuous glucose monitoring system, with the GoodFlip platform. The integration enables real-time glucose monitoring and data-driven management of diabetes, chronic kidney disease, post-transplant metabolic management and other metabolic conditions.
Through this partnership, the companies will deploy connected CGM solutions across digital care programmes and clinical pathways. By combining TRACKY’s biosensing technology with TatvaCare’s digital health infrastructure, clinicians will be able to monitor glucose trends remotely and support disease management for high-risk patient groups across India.
The partnership will also focus on care pathways for patients with chronic kidney disease and those requiring post-transplant metabolic management. These patient groups experience glycaemic variability due to immunosuppressive therapies, steroid use and metabolic changes, making continuous glucose monitoring relevant for glycaemic control and clinical outcomes.
TRACKY launched India’s first Bluetooth-connected continuous glucose monitoring system in 2025, enabling real-time transmission of glucose data to digital health platforms and expanding the role of CGM within data-driven metabolic health management.
Neeraj Katare, Founder of DrStore Healthcare Services India Private Limited, said, “Continuous monitoring technologies are redefining how metabolic diseases are managed globally. With TRACKY, our vision has been to build a connected biosensing platform that integrates advanced medical devices with digital health ecosystems. Launching India’s first Bluetooth-connected CGM was an important step in that journey. As adoption of continuous monitoring accelerates, we see tremendous potential in building an integrated metabolic monitoring ecosystem that enables clinicians and patients to move from episodic testing to real-time, data-driven care.”
Manoj Balaji, Chief Executive Officer at TatvaCare, said, “Digital health platforms are playing an increasingly critical role in enabling more personalised and continuous care pathways. By integrating TRACKY’s connected CGM technology within TatvaCare’s ecosystem, we aim to extend access to clinicians with deeper metabolic insights and enable patients to benefit from more proactive and technology-enabled disease management.”
For TRACKY, the collaboration forms part of a broader effort to build a continuous metabolic monitoring platform beyond glucose tracking. The company is working on technologies to enable monitoring of multiple metabolic and cardiovascular biomarkers through a unified platform.
The company is also exploring digital health applications supporting metabolic therapy management, including care models related to GLP-1-based weight-loss therapies. By combining biosensors, digital platforms and data insights, the approach aims to support metabolic health management.
As the burden of metabolic diseases such as diabetes, obesity and cardiovascular disorders rises, the integration of connected medical devices, biosensing and digital health platforms is being incorporated into chronic disease management systems in India.